Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide Combined With CBT for Adults With AUD and Overweight/Obesity
NCT07292519Phase 2Not yet recruiting
- Sponsor
- South Western Sydney Local Health District
- Start
- Jan 2026
- Primary completion
- May 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in alcohol use disorder (AUD), obesity, sponsored by South Western Sydney Local Health District. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
03
Conditions
alcohol use disorder (AUD)obesity
Beyond the preview
Go deeper on NCT07292519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07292519.